Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
SAFC: The Age of the Blockbuster Drug has ‘Disappeared’
10:31 PM MST | November 23, 2008 | Alex Scott
Sigma-Aldrich Fine Chemicals (SAFC), the fastest-growing division within the Sigma-Aldrich group, says it is adapting its business model to the “significantly” changing business environment. A fundamental change is the shift by big pharmaceutical companies away from blockbuster pharma products toward lower-volume, specialty drugs, says Frank Wicks, president of SAFC. Wicks: More flexibility is required. Pharma companies stand to lose $55 billion in sales during the next five years as a slew of drugs go off patent. “The specter of the blockbuster...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee